Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Acrux ( (AU:ACR) ) just unveiled an update.
Acrux Limited has announced the date for its upcoming Annual General Meeting (AGM), scheduled for November 25, 2025, in Melbourne. A key agenda item will be the election of directors, with nominations accepted until October 10, 2025. This meeting is significant for stakeholders as it will shape the company’s leadership and potentially influence its strategic direction.
More about Acrux
Acrux is a specialty pharmaceutical company with a strong track record in developing and commercializing topically applied pharmaceutical products. With 25 years of experience, the company has successfully marketed several products worldwide, focusing primarily on the United States.
Average Trading Volume: 462,200
Technical Sentiment Signal: Sell
Current Market Cap: A$5.73M
See more insights into ACR stock on TipRanks’ Stock Analysis page.